Inhibition of inducible nitric oxide synthesis by azathioprine in a macrophage cell line.

doi:10.1016/J.LFS.2006.01.015

Paper

DOI: 10.1016/J.LFS.2006.01.015

Inhibition of inducible nitric oxide synthesis by azathioprine in a macrophage cell line.

Published Jun 20, 2006 · T. Moeslinger, R. Friedl, P. Spieckermann

Life sciences

Q1 SJR score

Citations

Influential Citations

Full textSemantic Scholar

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

In Vitro Study

Study Snapshot

Azathioprine inhibits inducible nitric oxide synthesis in macrophages, contributing to its anti-inflammatory properties, suggesting potential for nontoxic anti-inflammatory agents.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Full text analysis coming soon...

References

DOI: 10.1038/sj.gt.3302552

Evaluation of a synthetic CArG promoter for nitric oxide synthase gene therapy of cancer

The synthetic CArG promoter pE9, incorporating nine radiosensitive CArG elements from the Egr1 promoter, effectively drives nitric oxide synthase gene therapy, resulting in a 7-day delay in tumor growth compared to the constitutive CMV-driven construct.

2005·33citations·Jane Worthington et al.·Gene Therapy

Gene Therapy

DOI: 10.1177/1087057103261446

Development of a High-Throughput Plate-Based Chemiluminescent Transcription Factor Assay

This high-throughput plate-based chemiluminescent assay effectively monitors activated levels of NFB and AP-1, providing valuable insights into cellular processes and their regulation.

2004·37citations·C. Rosenau et al.·Journal of Biomolecular Screening

Journal of Biomolecular Screening

DOI:

Infectious complications in 135 Turkish renal transplant patients.

Infectious complications are common in renal transplant patients, with E. coli being the most common urinary pathogen and HCV being the leading viral pathogen.

2002·20citations·Y. Oğuz et al.·Central European journal of public health

Central European journal of public health

DOI: 10.1016/S0014-2999(02)01947-7

Calcineurin inhibitors, cyclosporin A and tacrolimus inhibit expression of inducible nitric oxide synthase in colon epithelial and macrophage cell lines.

Cyclosporin A and tacrolimus effectively inhibit iNOS expression and nitric oxide production in colon epithelial and macrophage cells, potentially contributing to their anti-inflammatory effects in inflammatory bowel disease.

2002·56citations·M. Hämäläinen et al.·European journal of pharmacology

European journal of pharmacology

DOI:

KE-298 and its active metabolite KE-758 suppress nitric oxide production by murine macrophage cells and peritoneal cells from rats with adjuvant induced arthritis.

KE-758 suppresses nitric oxide production by murine macrophages and peritoneal cells from rats with adjuvant induced arthritis by inhibiting iNOS gene expression.

2001·14citations·Tomoyuki Inoue et al.·The Journal of rheumatology

The Journal of rheumatology

Citations

DOI: 10.1016/j.joen.2024.02.026

Prevalence of apical periodontitis in patients with autoimmune liver diseases under immune suppressants and immune modulators: a cross-sectional study.

Patients with autoimmune liver diseases undergoing treatment with immune suppressors have a lower prevalence of apical periodontitis compared to healthy individuals.

2024·3citations·F. Ideo et al.·Journal of endodontics

Journal of endodontics

DOI: 10.1016/j.intimp.2023.109989

Isochlorogenic acid A alleviates dextran sulfate sodium-induced ulcerative colitis in mice through STAT3/NF-кB pathway.

Isochlorogenic acid A (ICGA-A) alleviates experimental ulcerative colitis symptoms in mice by inhibiting the STAT3/NF-B signaling pathways, making it a promising and effective drug for treating UC.

2023·13citations·Shao-Qian Tang et al.·International immunopharmacology

International immunopharmacology

DOI: 10.3390/medicina59010056

Synthetic Pharmacotherapy for Systemic Lupus Erythematosus: Potential Mechanisms of Action, Efficacy, and Safety

Synthetic drugs like mycophenolate mofetil, azathioprine, and cyclophosphamide show promise in treating systemic lupus erythematosus, but their effectiveness and safety must be considered during therapy selection and monitoring.

2022·9citations·Angélica María Téllez Arévalo et al.·Medicina

Medicina

DOI: 10.1016/j.autrev.2022.103211

Macrophages in Lupus Nephritis: Exploring a potential new therapeutic avenue.

Macrophages may be potential therapeutic targets in lupus nephritis treatment, as they play a crucial role in inflammatory lesions and contribute to immune cell infiltration.

2022·27citations·Lianne E Kwant et al.·Autoimmunity reviews

Autoimmunity reviews

DOI: 10.3233/JPD-223278

Therapeutic Strategies for Immune Transformation in Parkinson’s Disease

Therapeutic strategies targeting innate and adaptive immunity, including vaccines, antibodies, and gene therapy, aim to improve clinical outcomes in Parkinson's disease by addressing chronic inflammation and neurodegeneration.

2022·11citations·Maamoon Saleh et al.·Journal of Parkinson's Disease

Journal of Parkinson's Disease

DOI: 10.5137/1019-5149.jtn.30237-20.2

Azathioprine as a Neuroprotective Agent in Experimental Traumatic Spinal Cord Injury.

Azathioprine, a macrophage inhibitor, effectively reduces secondary injury and improves neurological function in spinal cord trauma patients.

2020·1citation·Sinan Bahadır et al.·Turkish neurosurgery

Turkish neurosurgery

DOI: 10.1007/s00005-020-00576-4

Current Status of M1 and M2 Macrophages Pathway as Drug Targets for Inflammatory Bowel Disease

Novel IBD treatments target the immune system's pathway, aiming to regulate M1 and M2 macrophage distribution to favorably manage inflammatory bowel disease.

2020·53citations·Seyede Sara Seyedizade et al.·Archivum Immunologiae et Therapiae Experimentalis

Archivum Immunologiae et Therapiae Experimentalis

DOI: 10.1080/1547691X.2020.1748772

In vivo assessment of respiratory burst inhibition by xenobiotic exposure using larval zebrafish

Larval zebrafish are a useful model for identifying compounds that impact innate immune function at non-teratogenic levels, with benzo[a]pyrene showing the most significant increase in macrophage numbers.

2020·7citations·Drake Phelps et al.·Journal of Immunotoxicology

Journal of Immunotoxicology

DOI: 10.1097/mib.0000000000000946

Macrophages Versus Escherichia coli: A Decisive Fight in Crohn's Disease

In Crohn's disease, macrophages play a crucial role in causing intestinal damage and promoting gut health, and modulating their response could lead to new therapeutic targets and improved gut health.

2016·11citations·A. Buisson et al.·Inflammatory Bowel Diseases

Inflammatory Bowel Diseases